表紙
市場調查報告書

北美臨床檢查服務成長機會、成長預測:∼2022年

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

出版商 Frost & Sullivan 商品編碼 816180
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
北美臨床檢查服務成長機會、成長預測:∼2022年 Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022
出版日期: 2019年03月20日內容資訊: 英文 92 Pages
簡介

臨床檢查服務是北美地區醫療費支出中佔最大支出額的部門之一,但美國和加拿大展現了不同的策畫。2017年的紀錄,加拿大市場規模推估是103億3000萬美元,美國則推估規模是783億3000萬美元。

本報告調查了北美臨床檢查服務市場,統整了美國及加拿大的主要趨勢、市場成長推動因素、抑制因素分析、M&A和簽約等趨勢、獲利變化、預測、市佔率、主要企業檔案、成長策略、成功條件分析等。

第1章 執行指南

第2章 成長環境、市場概要

  • 市場環境:美國
  • 市場環境:加拿大
  • 主要動向
  • 臨床服務提供者選定因素
  • 為了存活的成功策略

第3章 願景與戰略: 成長機會

  • 臨床實驗的焦點區
  • 成長機會:替代獲利途徑摸索
  • 成長機會:病理、基因組學資料組合的轉型照護實踐
  • 成長機會:變化的照護支援用的區塊鏈

第4章 臨床檢查服務市場預測:美國

  • 市場概況
  • 主要動向
  • 市場成長促進因素
  • 市場成長阻礙因素
  • PAMA對應策略
  • M&A分析
  • 主要契約

第5章 獲利預測□市佔率分析:美國

  • 市場工程測定
  • 預測前提因素
  • 收益預測
  • 收益預測:實驗室類型別
  • 市佔率分析

第6章 美國臨床檢查服務市場:主要資料

第7章 Tier1公司檔案

  • Quest Diagnostics
  • LabCorp
  • BioReference Laboratories (OPKO Health)
  • Myriad Genetics

第8章 臨床檢查服務市場預測:加拿大

  • 市場概況
  • 主要動向
  • 市場成長促進因素
  • 市場成長阻礙因素
  • 供應商概要
  • 地區分析:償付
  • 地區分析:展望
  • 地區分析:價格差異
  • 地區分析:檢查對像差異
  • 基因檢查外包

第9章 獲利預測□市佔率分析:加拿大

  • 市場工程測定
  • 預測前提因素
  • 收益預測
  • 收益預測:實驗室類型別
  • 市佔率分析

第10章 Tier1公司檔案

  • LifeLabs
  • Dynacare
  • DynaLIFE Dx

第11章 總論

目錄
Product Code: K335-55

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 billion for the same year. Heavily influenced by the Protecting Access to Medicare Act (PAMA) reimbursement cuts, US laboratories are expanding their revenue streams to collaborate with retail clinics and eCommerce channels to increase their testing footprint. Today's market is ripe for mergers and acquisitions. The private market is heavily concentrated between two reference laboratories, Quest Diagnostics and LabCorp.

This report analyzes the market for clinical laboratory services in North America across 3 main segments: hospital laboratories, physician office laboratories, and specialty/independent laboratories. In Canada, regional public laboratories are also analyzed. Revenue forecasts for the period 2018-2022 have been carefully studied to understand the impact of PAMA and the upcoming reimbursement cuts. The study also includes competitive profiles of top vendors serving the United States and Canada for laboratory testing and gives an in-depth analysis of winning strategies for laboratories to survive in a future that is governed by value-based healthcare. Since the market is ripe for mergers and acquisitions, a detailed M&A analysis for the period 2017-2018 is included.

In Canada, lab services as well as any innovation pertaining to the introduction of new tests are heavily dependent on Ministry of Health (MoH) funding. Some provinces are more open than others (e.g., Ontario is more open to innovation and introduction of new tests when compared to Quebec.). Ontario, British Columbia, and Quebec are the major markets within Canada. Although similar in the flow of funds and governance by their respective MoHs, it is important to note there is a huge pricing difference observed for clinical tests in each Canadian province. There are downsides to the clinical lab services market in Canada given that several medically necessary tests remain uninsured and not paid for by the MoH. These are covered through private insurance. Also, a substantial amount of outsourcing occurs for genetic testing (sent to the United States, mostly) because of an inadequate strategy for this type of testing.

Other areas covered in this research are challenges and drivers impacting the clinical lab services market in the United States and Canada; new business models and alternate revenue channels; winning strategies for clinical labs to combat reimbursement pressure; actionable growth opportunities for companies; and major lab chains by country.

Table of Contents

1. EXECUTIVE DASHBOARD

  • Purpose of this Experiential Study
  • 5 Step Process to Transformational Growth
  • Scope and Segmentation-United States
  • Scope and Segmentation-United States (continued)
  • Scope and Segmentation-Canada
  • Scope and Segmentation-Canada (continued)
  • Market Highlights
  • Market Highlights (continued)
  • Strategic Imperatives for Laboratories
  • Key Questions this Study will Answer
  • Top 3 Predictions

2. GROWTH ENVIRONMENT-MARKET OVERVIEW

  • US Clinical Laboratories Market Landscape
  • Canadian Clinical Laboratories Market Landscape
  • Key Trends in the North American Clinical Services Market
  • Key Trends in the North American Clinical Services Market (continued)
  • Factors Considered When Choosing a Clinical Service Provider
  • Winning Strategies for Labs to Survive
  • Winning Strategies for Labs to Survive (continued)

3. VISION AND STRATEGY-GROWTH OPPORTUNITIES

  • Key Focus Areas for Clinical Laboratories
  • Growth Opportunity 1-Seeking Alternate Revenue Channel
  • Growth Opportunity 2-Transformative Care Practices Combining Pathology and Genomics Data
  • Growth Opportunity 3-Blockchain for Transforming Care Pathways

4. US CLINICAL LABORATORY SERVICES MARKET FORECASTS

  • US Clinical Laboratory Services Market Snapshot
  • Top Clinical Laboratory Services Trends (US)
  • Market Drivers
  • Market Restraints
  • Strategies to Combat PAMA
  • Merger and Acquisition Analysis
  • Summary of Merger and Acquisition Trends
  • Notable Deals of 2017 and 2018
  • Notable Deals of 2017 and 2018 (continued)
  • Notable Deals of 2017 and 2018 (continued)

5. REVENUE FORECAST AND MARKET SHARE ANALYSIS-THE UNITED STATES

  • Market Engineering Measurements
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Lab Type
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Market Share Analysis (continued)
  • Market Share Analysis (continued)

6. UNDERSTANDING US CLINICAL LABORATORY SERVICES MARKET BY NUMBERS

  • US Clinical Laboratory Services by Numbers
  • Number of Labs by Specialty
  • US Clinical Laboratory Services Overview
  • US Clinical Laboratory Services Overview (continued)
  • US Clinical Laboratory Services Overview (continued)

7. COMPANY PROFILES-TIER I

  • Quest Diagnostics
  • LabCorp
  • BioReference Laboratories (OPKO Health)
  • Myriad Genetics

8. CANADIAN CLINICAL LABORATORY SERVICES MARKET FORECASTS

  • Canadian Clinical Laboratory Services Market Snapshot
  • Top Trends in Canadian Clinical Laboratory Services Market
  • Market Drivers
  • Market Restraints
  • Snapshot of Clinical Laboratory Providers (By Numbers)
  • Provincial Analysis-Reimbursement
  • Provincial Analysis-Outlook
  • Provincial Analysis-Outlook (continued)
  • Provincial Analysis-Pricing Differences
  • Provincial Analysis-Coverage Variations
  • Genetic Testing Outsourcing

9. REVENUE FORECAST AND MARKET SHARE ANALYSIS-CANADA

  • Market Engineering Measurements
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Lab Type
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Market Share Analysis-Private Lab Market

10. COMPANY PROFILES-TIER I

  • LifeLabs
  • Dynacare
  • DynaLIFE Dx

11. LAST WORD

  • Key Conclusions and Future Outlook
  • Legal Disclaimer
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)